
GRAIL's PATHFINDER 2 study shows Galleri blood test detected 7 times more cancers when added to standard screenings, with 99.6% specificity and low false positives.

Editor of Patient Care Online.

GRAIL's PATHFINDER 2 study shows Galleri blood test detected 7 times more cancers when added to standard screenings, with 99.6% specificity and low false positives.

Your daily dose of the clinical news you may have missed.

A family medicine physician shares a case of massive PE presenting as syncope and explains the history questions that prevent missed DVT diagnoses in primary care.

Primary care physicians enhance early detection and management of vascular diseases, emphasizing patient history, screening, and strong relationships for better outcomes.

Your daily dose of the clinical news you may have missed.

A multidisciplinary lung cancer screening program significantly boosts screening rates, ensuring timely follow-ups and early diagnoses for eligible patients.

Your daily dose of the clinical news you may have missed.

FMX 2025 highlights for primary care include expert insights on vaccine confidence, chronic cough management, and vascular disease prevention.

Highlights include size-based surveillance protocols, referral timing, cardiovascular risk reduction, and coordination with vascular surgery.

Merck reveals promising phase 3 results for DOR/ISL, showing minimal impact on weight and lipids in adults with suppressed HIV-1.

A study reveals that starting benzodiazepines or antipsychotics in hospice patients with dementia significantly increases 180-day mortality, urging careful prescribing.

Your daily dose of the clinical news you may have missed.

Step-by-step treatment protocol for upper airway cough syndrome including nasal steroids, antihistamines, and proper administration technique.

FDA approves updated indication for upadacitinib in ulcerative colitis and Crohn disease treatment, allowing use after one systemic therapy when TNF blockers are clinically inadvisable.

Your daily dose of the clinical news you may have missed.

Emergency medicine physician Kabiul Haque, MD, discusses USPSTF screening guidelines for abdominal aortic aneurysm.

Kabiul Haque, MD, a family medicine physician, shares his four-pillar approach to preventing PAD progression.

New research reveals GLP-1 receptor agonists may alter PET-CT scan interpretations, highlighting the need for updated guidelines in oncological imaging.

From dense breast notification laws to changing lung and cervical screening criteria, experts share practical strategies to help navigate today’s evolving cancer prevention landscape.

Practical insights from FMX 2025 to help primary care physicians apply new evidence, guidelines, and patient-care strategies in daily practice.

A family medicine physician details how to differentiate upper airway cough syndrome from asthma and GERD using clinical history and associated symptoms.

Upper airway cough syndrome is the main cause of chronic cough. A family medicine physician shares the clinical red flags that should make you suspect UACS in your primary care patients.

FMX 2025: A family medicine clinician discusses the clinical significance of acute, subacute, and chronic cough timeframes and their differential diagnoses.

Sarah C. Nosal, MD, FAAFP, takes the helm as AAFP President, emphasizing community-focused family medicine and innovative healthcare solutions.

Discover essential insights and innovative strategies at FMX 2025, featuring key topics like AI in healthcare and advancements in family medicine.

Get a first look at can’t-miss sessions from day 2 of FMX 2025—from vaccines and metabolic health to dementia, women’s care, and AI in family medicine.

From vaccines to reproductive health to AI, here are 16 sessions you won't want to miss at FMX 2025.

Today's episode highlights arrhythmias as CVD risk markers, influenza vaccine safety, salt substitute use, preconception CT scan risks, and global diabetes care gaps.

Evolocumab significantly reduced major cardiovascular events in high-risk patients without prior heart attack or stroke, making it the first PCSK9 inhibitor with proven benefit in both primary and secondary prevention.

Preview the top sessions at the AAFP Family Medicine Experience (FMX) 2025. From vaccines and obesity care to dementia and LGBTQ+ health, here are 10 highlights for family physicians.